About Us

Telix Pharmaceuticals was created to deliver on the promise of nuclear medicine


The field of nuclear medicine has historically lacked clinical momentum and commitment to late-stage product development. Our goal is to rectify this for the benefit of patients.

Since the latest edition of Baselworld, in 2015, it also features a new in-house movement, the Calibre MT5612. And it leads us to this simple conclusion: there will be more variations of this movement in the coming years! replicawatches.to Therefore, we imagined the first one, will be with a GMT complication, something that we know to be extremely useful and rather applauded by potential clients – and that its missing in the actual Tudor catalogue (indeed, theres no GMT watches in the current Tudor line up). We also know that the base movement can easily accept extra-complications, like its the case with the North Flag, which features a power reserve.

Latest News


Telix at ANZSNM Annual Scientific Meeting 2022

9 May 2022 – Corporate Spotlight | Telix supporting and participating in Australian and New Zealand Society of Nuclear Medicine...


First Patient Dosed in Phase II Renal Cancer Theranostics Study

Melbourne (Australia) and Indianapolis, IN (U.S.A.) – 5 May 2022. Telix announces that a first patient has been dosed in...


Telix Further Strengthens European Distribution Network for Illuccix

Melbourne (Australia) and Liège (Belgium)– 22 April 2022. Telix announces agreements with Avanço and THP for the distribution of Telix’s...


Activities Report and Appendix 4C for March 2022 Quarter

Melbourne (Australia) – 22 April 2022. Telix issues Appendix 4C quarterly cash flow statement and accompanying Activities Report for the...